One preliminary experience in adults suggested that the use of the IL-6 receptor antibody tocilizumab is beneficial in patients with hematological malignancy who suffer from elevated IL-6 levels caused by severe sepsis [13]. The gene discussed is IL6; the disease is Sepsis.